Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic mice

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Eguchi, Megumi ^a,d   Kim, Young Hwa ^b   Kang, Keon Wook ^b   Shim, Chi Young ^c   Jang, Yangsoo ^c   Dorval, Thierry ^a   Kim, Kwang Joon ^c   Sweeney, Gary ^a,d  

^a Institute Pasteur Korea   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; FLUORODEOXYGLUCOSE F 18; STREPTOZOCIN; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CARDIAC REMODELING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIABETES MELLITUS; ECHOCARDIOGRAPHY; GLUCOSE METABOLISM; HEART CONTRACTION; HEART DILATATION; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE WALL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MACROPHAGE; MOUSE; MOUSE STRAIN; NICK END LABELING; NONHUMAN; REPERFUSION INJURY; STREPTOZOCIN DIABETES; SYSTOLE; TISSUE SECTION; ANIMAL; ELECTROCARDIOGRAPHY; EXPERIMENTAL DIABETES MELLITUS; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY;

ANIMALIA; MUS;

ANIMALS; AUTOPHAGY; DIABETES MELLITUS, EXPERIMENTAL; ELECTROCARDIOGRAPHY; GLUCOSE; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84863044821     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030450     Document Type: Article

References (48)

1. Flaherty JD, Davidson CJ, (2005) Diabetes and coronary revascularization. JAMA 293: 1501-1508.
2. Fisher BM, (1997) Heart abnormalities in IDDM. Diabetologia 40 (Suppl 2): S127-129.
3. Katayama T, Nakashima H, Takagi C, Honda Y, Suzuki S, et al. (2005) Clinical outcomes and left ventricular function in diabetic patients with acute myocardial infarction treated by primary coronary angioplasty. Int Heart J 46: 607-618.
4. Bugger H, Abel ED, (2009) Rodent models of diabetic cardiomyopathy. Dis Model Mech 2: 454-466.
5. Breckenridge R, (2010) Heart failure and mouse models. Dis Model Mech 3: 138-143.
6. Abel ED, Litwin SE, Sweeney G, (2008) Cardiac remodeling in obesity. Physiol Rev 88: 389-419.
7. Dahab GM, Kheriza MM, El-Beltagi HM, Fouda AM, El-Din OA, (2004) Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software. J Gastroenterol Hepatol 19: 78-85.
8. Kofoed KF, Schoder H, Knight RJ, Buxton DB, (2000) Glucose metabolism in reperfused myocardium measured by [2-18F] 2-fluorodeoxyglucose and PET. Cardiovasc Res 45: 321-329.
9. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728.
10. Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, et al. (2010) Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23: 351-369; quiz 453-355.
11. Taha M, Lopaschuk GD, (2007) Alterations in energy metabolism in cardiomyopathies. Ann Med 39: 594-607.
12. Kantor PF, Dyck JR, Lopaschuk GD, (1999) Fatty acid oxidation in the reperfused ischemic heart. Am J Med Sci 318: 3-14.
13. Finegan BA, Lopaschuk GD, Coulson CS, Clanachan AS, (1993) Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation 87: 900-908.
14. Broderick TL, Quinney HA, Barker CC, Lopaschuk GD, (1993) Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation 87: 972-981.
15. Lopaschuk GD, Wall SR, Olley PM, Davies NJ, (1988) Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ Res 63: 1036-1043.
16. Lopaschuk GD, Spafford MA, Davies NJ, Wall SR, (1990) Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 66: 546-553.
17. Carvalho G, Pelletier P, Albacker T, Lachapelle K, Joanisse DR, et al. (2011) Cardioprotective Effects of Glucose and Insulin Administration While Maintaining Normoglycemia (GIN Therapy) in Patients Undergoing Coronary Artery Bypass Grafting. J Clin Endocrinol Metab 96: 1469-1477.
18. Sugimoto S, (2007) A novel vacuolar myopathy with dilated cardiomyopathy. Autophagy 3: 638-639.
19. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, et al. (2005) Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A 102: 13807-13812.
20. Kostin S, Pool L, Elsasser A, Hein S, Drexler HC, et al. (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92: 715-724.
21. Gottlieb RA, Mentzer RM, (2010) Autophagy during cardiac stress: joys and frustrations of autophagy. Annu Rev Physiol 72: 45-59.
22. Gustafsson AB, Gottlieb RA, (2008) Eat your heart out: Role of autophagy in myocardial ischemia/reperfusion. Autophagy 4: 416-421.
23. Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K, (2009) The role of autophagy in the heart. Cell Death Differ 16: 31-38.
24. Whelan RS, Kaplinskiy V, Kitsis RN, (2010) Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 72: 19-44.
25. Hamacher-Brady A, Brady NR, Gottlieb RA, (2006) Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 281: 29776-29787.
26. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, et al. (2007) Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 100: 914-922.
27. Gustafsson AB, Gottlieb RA, (2003) Mechanisms of apoptosis in the heart. J Clin Immunol 23: 447-459.
28. Rabinowitz JD, White E, (2010) Autophagy and metabolism. Science 330: 1344-1348.
29. Levine B, Kroemer G, (2008) Autophagy in the pathogenesis of disease. Cell 132: 27-42.
30. Salih DA, Brunet A, (2008) FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 20: 126-136.
31. Boudina S, Bugger H, Sena S, O'Neill BT, Zaha VG, et al. (2009) Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 119: 1272-1283.
32. Zhu H, Tannous P, Johnstone JL, Kong Y, Shelton JM, et al. (2007) Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 117: 1782-1793.
33. Lutz J, Thurmel K, Heemann U, (2010) Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm (Lond) 7: 27.
34. Sisley AC, Desai T, Harig JM, Gewertz BL, (1994) Neutrophil depletion attenuates human intestinal reperfusion injury. J Surg Res 57: 192-196.
35. Frangogiannis NG, Smith CW, Entman ML, (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47.
36. Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, et al. (2010) Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol 49: 499-507.
37. Ren J, Yang M, Qi G, Zheng J, Jia L, et al. (2011) Proinflammatory Protein CARD9 Is Essential for Infiltration of Monocytic Fibroblast Precursors and Cardiac Fibrosis Caused by Angiotensin II Infusion. Am J Hypertens 24: 701-707.
38. Pfeffer MA, (1995) Left ventricular remodeling after acute myocardial infarction. Annu Rev Med 46: 455-466.
39. Cleland JG, Torabi A, Khan NK, (2005) Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart 91 (Suppl 2): ii7-13; discussion ii31, ii43-18.
40. Aragno M, Mastrocola R, Alloatti G, Vercellinatto I, Bardini P, et al. (2008) Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149: 380-388.
41. Ban CR, Twigg SM, (2008) Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag 4: 575-596.
42. Li Q, Wang Y, Sun SZ, Tian YJ, Liu MH, (2010) Effects of benazepril on cardiac fibrosis in STZ-induced diabetic rats. Acta Cardiol 65: 431-439.
43. Foy SG, Crozier IG, Richards AM, Nicholls MG, Turner JG, et al. (1995) Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition. Eur Heart J 16: 770-778.
44. Sechi LA, Griffin CA, Schambelan M, (1994) The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 43: 1180-1184.
45. Weber KT, Brilla CG, (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865.
46. Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME, (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121: 748-757.
47. Verma A, Anavekar NS, Meris A, Thune JJ, Arnold JM, et al. (2007) The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study. J Am Coll Cardiol 50: 1238-1245.
48. Verma A, Meris A, Skali H, Ghali JK, Arnold JM, et al. (2008) Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc Imaging 1: 582-591.